Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary


Vanda Pharmaceuticals is owned by 10.77% institutional investors, 7.20% insiders, and 82.02% retail investors. Blackrock is the largest institutional shareholder, holding 14.09% of VNDA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals10.77%7.20%82.02%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.14M14.09%$45.98M
Blackrock funding, inc. /de7.77M13.19%$68.56M
Vanguard group3.73M6.34%$32.91M
Renaissance3.38M5.74%$29.82M
Acadian asset management2.41M4.09%$21.25M
Tang capital management2.35M3.99%$11.74M
Millennium management2.14M3.66%$9.82M
Dimensional fund advisors lp2.12M3.59%$18.68M
Aigh capital management2.00M3.39%$17.63M
Jacobs levy equity management1.49M2.57%$8.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management2.00M4.27%$17.63M
Krensavage asset management1.18M2.51%$5.89M
Empire financial management company1.11M2.12%$9.77M
Tang capital management2.35M0.45%$11.74M
Monaco asset management sam196.29K0.30%$1.73M
Caitong asset management10.39K0.25%$91.63K
Pharvision advisers57.04K0.16%$284.62K
Gsa capital partners llp148.76K0.11%$1.31M
One68 global capital26.06K0.06%$119.61K
Inscription capital63.88K0.06%$563.40K

Top Buyers

HolderShares% AssetsChange
Aigh capital management2.00M4.27%2.00M
Millennium management2.14M0.01%1.47M
Empire financial management company1.11M2.12%350.15K
Jpmorgan chase396.02K0.00%196.12K
Acadian asset management2.41M0.03%181.67K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.59M
Blackrock funding, inc. /de7.77M0.00%-1.14M
Bank of america corp /de/77.42K--1.13M
Assenagon asset management---730.82K
Marshall wace, llp---581.25K

New Positions

HolderShares% AssetsChangeValue
Aigh capital management2.00M4.27%2.00M$17.63M
Janney montgomery scott175.54K0.00%175.54K$1.55M
Jump financial138.00K0.01%138.00K$688.62K
Norges bank115.00K0.00%115.00K$550.85K
Cubist systematic strategies63.82K0.00%63.82K$318.47K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Nelson, van denburg & campbell wealth management group-10.00
Gps wealth strategies group-25.00
Assetmark-31.00
Bokf, na-44.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202538-75.64%6,341,924-85.88%100.19%17-76.06%12-77.36%
Sep 30, 202551-64.34%6,811,734-84.86%110.20%22-67.65%15-67.39%
Jun 30, 2025142-7.79%44,993,3852.43%761.35%673.08%46-16.36%
Mar 31, 20254-97.33%2,360,082-94.49%40.07%3-95.95%--100.00%
Dec 31, 2024140-11.39%41,400,330-5.62%711.25%71-2.74%39-23.53%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.74M2.99%-
Vanguard Total Stock Mkt Idx Inv1.76M2.98%-
iShares Russell 2000 ETF1.34M2.26%172.71K
Vanguard Institutional Extnd Mkt Idx Tr642.77K1.09%-9.43K
Fidelity Small Cap Index556.05K0.94%-661.00
BlackRock Advantage Small Cap Core Instl546.95K0.93%-196.11K
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K
iShares Russell 2000 Value ETF485.42K0.82%-57.55K
DFA US Targeted Value I444.72K0.75%13.19K
Federated Hermes MDT Small Cap Core IS430.41K0.73%-194.14K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 02, 2026Williams Timothy SVP & General CounselSell$350.76K
Mar 02, 2026Moran Kevin Patrick SVP, CFO & TreasurerSell$350.82K
Mar 02, 2026Wijkstrom Joakim SVP, Chief Marketing OfficerSell$254.59K
Mar 02, 2026Polymeropoulos Mihael Hristos President and CEOSell$1.28M
Mar 02, 2026Birznieks Gunther SVP, Business DevelopmentSell$350.73K

Insider Transactions Trends


DateBuySell
2026 Q1-6
2025 Q31-
2025 Q231
2025 Q111-
2024 Q4-1

VNDA Ownership FAQ


Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 10.77%, followed by 7.20% insiders and 82.03% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Vanda Pharmaceuticals falls below.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock (8.14M shares, 14.09%), Blackrock funding, inc. /de (7.77M shares, 13.19%), and Vanguard group (3.73M shares, 6.34%). Together, they hold 33.62% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.27% of its assets in 2M Vanda Pharmaceuticals shares, valued at 17.63M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools